For most people with moderate to severe depression, antidepressants provide a meaningful improvement in symptoms, though they work better than a placebo by a smaller margin than many people assume. About 50% of adults with depression respond to antidepressant medication, compared to 31% who improve on placebo. That 19-percentage-point gap is real, but it means the benefit you feel may partly come from the medication’s direct effects and partly from other factors like expectation, routine, and clinical support.
Whether that gap is “worth it” depends on how severe your depression is, how you respond to side effects, and whether you’ve considered or tried alternatives. Here’s what the evidence actually shows.
How Well Antidepressants Work by Severity
The clearest finding across multiple meta-analyses is that antidepressants show the strongest benefit over placebo in severe depression. For mild depression, the advantage over placebo is small enough that it’s hard to distinguish from no effect at all. The evidence for moderate depression is mixed, with some analyses finding a meaningful benefit and others not.
Clinical guidelines reflect this gradient. Therapy is considered a reasonable first-line option for mild to moderate depression, while medication becomes more strongly recommended as severity increases. For severe depression, especially with psychotic features or significant disruption to sleep, appetite, and daily functioning, medication is typically considered essential. None of this means antidepressants can’t help someone with moderate symptoms. It means the odds of a noticeable benefit over doing nothing (or over therapy alone) go up as depression gets worse.
What Antidepressants Actually Do in Your Brain
The old explanation that depression is a “chemical imbalance” of serotonin has largely been retired by researchers. A widely cited 2022 review found no consistent evidence that depression is caused by low serotonin levels. That doesn’t mean SSRIs don’t work. It means the reason they work is more complicated than topping off a depleted brain chemical.
Current thinking focuses on brain circuitry involved in emotional processing, reward, and decision-making. Antidepressants appear to promote neuroplasticity, the brain’s ability to form and strengthen connections between neurons. Chronic antidepressant use boosts the production of a growth factor called BDNF, which increases the density of connections between brain cells and strengthens signaling in areas like the hippocampus. Think of it less like filling a tank and more like helping your brain rewire patterns that depression has locked into place. This rewiring process is also why antidepressants take weeks to kick in rather than working immediately.
The Timeline for Feeling Better
Most people don’t notice a mood improvement for two to four weeks after starting an antidepressant. Physical symptoms like sleep disruption and low energy often improve first. The lift in mood, motivation, and negative thinking patterns tends to come later and more gradually. This mismatch matters: you may feel more physically energized before your outlook has changed, which is one reason the early weeks of treatment require close monitoring.
If you’ve been on an antidepressant for six to eight weeks at an adequate dose with no improvement, that particular medication probably isn’t the right fit. Switching to a different one or adding therapy often follows.
Antidepressants vs. Therapy
A large systematic review and meta-analysis published in the BMJ found no statistically significant difference in effectiveness between SSRIs and cognitive behavioral therapy (CBT) for depression. Response rates, remission rates, and symptom scores were comparable. This held true whether the treatments were used alone or in combination, though the authors noted that small sample sizes may have obscured modest differences.
In practice, the choice often comes down to access, preference, and severity. Therapy requires consistent appointments over weeks or months, and availability can be limited. Medication is easier to access but comes with physical side effects. For many people, the combination of both works better than either alone, especially for moderate to severe depression. If your depression is mild, therapy alone is a reasonable first step before considering medication.
Side Effects That Matter Most
The side effects people worry about most are sexual dysfunction, weight gain, and emotional blunting. The numbers on sexual dysfunction are striking: in original clinical trials, only about 2% of participants spontaneously reported it. But when researchers asked directly using questionnaires, the rate jumped to 55% for SSRIs. This means the majority of people on these medications experience some degree of reduced desire, difficulty with arousal, or trouble reaching orgasm. Many don’t mention it to their doctor unless asked.
Weight gain is also common with longer use. Uncontrolled studies have reported average gains of 15 to 24 pounds over 6 to 12 months, depending on the specific medication. Anxiety, agitation, and sleep disturbance are most frequently associated with certain SSRIs, particularly in the early weeks of treatment. These side effects are the primary reason people stop taking antidepressants, and they deserve honest discussion before starting.
What Happens When You Stop
About 20% of people who abruptly stop an antidepressant after taking it for at least a month develop discontinuation syndrome. Symptoms can include dizziness, nausea, irritability, “brain zaps” (brief electric-shock sensations), vivid dreams, and flu-like feelings. This isn’t the same as relapse, though it can be hard to tell the difference in the moment.
Tapering gradually over six to eight weeks significantly reduces the risk. If you’re considering stopping, doing it slowly and with guidance makes the process substantially easier. Some medications with shorter durations of action in the body are more likely to cause withdrawal symptoms than others.
Long-Term Use: What the Data Shows
Many people take antidepressants for years or even decades, but long-term safety data is still evolving. A large population-based cohort study found that SSRI use over 10 years was associated with a lower risk of developing diabetes (about 32% lower) and hypertension (about 23% lower) compared to untreated individuals. However, the same study found that long-term SSRI use was associated with increased risks of cardiovascular disease, cardiovascular mortality, and all-cause mortality at the 10-year mark. There was also some evidence of a dose-response effect, meaning higher doses carried higher risk.
These are observational findings, not proof that the medications directly cause heart problems. People who take antidepressants long-term may differ in important ways from those who don’t, including having more severe or chronic depression, which itself carries cardiovascular risk. Still, the data suggests that staying on antidepressants indefinitely isn’t a decision to make on autopilot. Periodic reassessment of whether the benefits still outweigh the risks makes sense, particularly after several years.
Who Benefits Most
Antidepressants are most clearly worth it for people with moderate to severe depression who have significant impairment in daily life, especially when symptoms include major disruptions to sleep, appetite, energy, or concentration. A history of responding well to antidepressants in the past is one of the strongest predictors that they’ll work again. People who anticipate needing long-term maintenance treatment to prevent recurrent episodes also tend to benefit.
For mild depression, the medication-over-placebo advantage is small, and structured therapy, regular exercise, and lifestyle changes may deliver similar results without the side effect burden. For children and adolescents, the picture is murkier: the placebo response rate is 46% compared to 59% for medication, making the true drug effect even narrower than in adults.
The honest answer is that antidepressants are a genuinely useful tool for a specific range of situations, not a universal fix. They work meaningfully better than placebo for many people, but roughly half of those who try them won’t respond to the first one they’re prescribed. The side effects are real and underreported. And they perform about as well as good therapy for most severity levels. Whether they’re worth it for you depends on where you fall on that spectrum and what alternatives you have access to.